| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | ABCF3 CENPE NAIP DNAH2 MYO18A RFC1 DHX8 BPTF ABCA6 DNAH17 MLH1 ATP11C ATP11A HSPA4 | 2.87e-06 | 614 | 102 | 14 | GO:0140657 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 8.68e-05 | 441 | 102 | 10 | GO:0016887 | |
| GeneOntologyMolecularFunction | phosphatidylserine flippase activity | 2.56e-04 | 5 | 102 | 2 | GO:0140346 | |
| GeneOntologyMolecularFunction | dATP binding | 2.56e-04 | 5 | 102 | 2 | GO:0032564 | |
| GeneOntologyMolecularFunction | adenyl deoxyribonucleotide binding | 3.82e-04 | 6 | 102 | 2 | GO:0032558 | |
| GeneOntologyMolecularFunction | unfolded protein binding | 4.72e-04 | 126 | 102 | 5 | GO:0051082 | |
| GeneOntologyMolecularFunction | aminophospholipid flippase activity | 5.34e-04 | 7 | 102 | 2 | GO:0015247 | |
| GeneOntologyMolecularFunction | purine deoxyribonucleotide binding | 5.34e-04 | 7 | 102 | 2 | GO:0032554 | |
| GeneOntologyMolecularFunction | phosphatidylethanolamine flippase activity | 5.34e-04 | 7 | 102 | 2 | GO:0090555 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | ABCF3 NAIP DNAH2 MYO18A RFC1 DHX8 ARFRP1 ABCA6 MLH1 RAB7A ATP11C ATP11A | 5.90e-04 | 775 | 102 | 12 | GO:0017111 |
| GeneOntologyMolecularFunction | deoxyribonucleotide binding | 9.09e-04 | 9 | 102 | 2 | GO:0032552 | |
| GeneOntologyMolecularFunction | phosphatidylserine floppase activity | 9.09e-04 | 9 | 102 | 2 | GO:0090556 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | ABCF3 NAIP DNAH2 MYO18A RFC1 DHX8 ARFRP1 ABCA6 MLH1 RAB7A ATP11C ATP11A | 1.18e-03 | 839 | 102 | 12 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | ABCF3 NAIP DNAH2 MYO18A RFC1 DHX8 ARFRP1 ABCA6 MLH1 RAB7A ATP11C ATP11A | 1.19e-03 | 840 | 102 | 12 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | ABCF3 NAIP DNAH2 MYO18A RFC1 DHX8 ARFRP1 ABCA6 MLH1 RAB7A ATP11C ATP11A | 1.19e-03 | 840 | 102 | 12 | GO:0016818 |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | SPATA7 CENPE CCDC146 CEP295NL DNAH2 FSIP2 DST IFT88 DNAH17 SYNE2 ASPM MLH1 TAOK1 PIBF1 CFAP46 | 1.94e-06 | 720 | 100 | 15 | GO:0000226 |
| GeneOntologyBiologicalProcess | axoneme assembly | 1.51e-05 | 109 | 100 | 6 | GO:0035082 | |
| GeneOntologyBiologicalProcess | organelle assembly | NEBL CENPE CCDC146 CEP295NL DNAH2 NEB FSIP2 IFT52 IFT88 MTOR DNAH17 SYNE2 ASPM MLH1 RAB7A PIBF1 CFAP46 | 3.12e-05 | 1138 | 100 | 17 | GO:0070925 |
| GeneOntologyBiologicalProcess | microtubule-based process | SPATA7 CENPE CCDC146 CEP295NL DNAH2 FSIP2 IFT52 DST IFT88 DNAH17 SYNE2 ASPM MLH1 TAOK1 PIBF1 CFAP46 | 4.75e-05 | 1058 | 100 | 16 | GO:0007017 |
| GeneOntologyBiologicalProcess | cardiac muscle thin filament assembly | 6.96e-05 | 3 | 100 | 2 | GO:0071691 | |
| GeneOntologyBiologicalProcess | microtubule bundle formation | 7.54e-05 | 145 | 100 | 6 | GO:0001578 | |
| GeneOntologyBiologicalProcess | positive regulation of pentose-phosphate shunt | 1.39e-04 | 4 | 100 | 2 | GO:1905857 | |
| GeneOntologyBiologicalProcess | microtubule-based movement | CENPE CCDC146 DNAH2 FSIP2 IFT52 DST IFT88 DNAH17 SYNE2 CFAP46 | 1.41e-04 | 493 | 100 | 10 | GO:0007018 |
| GeneOntologyCellularComponent | sperm head-tail coupling apparatus | 8.73e-05 | 18 | 102 | 3 | GO:0120212 | |
| Domain | TPR-like_helical_dom | SAMD9 PSMD11 ST13 TMTC3 IFT88 MTOR NUB1 ST13P5 ANAPC7 CFAP46 | 4.89e-07 | 233 | 100 | 10 | IPR011990 |
| Domain | TPR_6 | 2.84e-05 | 2 | 100 | 2 | PF13174 | |
| Domain | TPR_REGION | 2.97e-05 | 165 | 100 | 7 | PS50293 | |
| Domain | TPR | 2.97e-05 | 165 | 100 | 7 | PS50005 | |
| Domain | - | 1.24e-04 | 207 | 100 | 7 | 1.25.40.10 | |
| Domain | Nebulin | 1.69e-04 | 4 | 100 | 2 | PF00880 | |
| Domain | NEBULIN | 1.69e-04 | 4 | 100 | 2 | PS51216 | |
| Domain | NEBU | 1.69e-04 | 4 | 100 | 2 | SM00227 | |
| Domain | Nebulin | 1.69e-04 | 4 | 100 | 2 | IPR013998 | |
| Domain | Nebulin_repeat | 1.69e-04 | 4 | 100 | 2 | IPR000900 | |
| Domain | TPR_8 | 1.85e-04 | 53 | 100 | 4 | PF13181 | |
| Domain | TPR | 6.48e-04 | 129 | 100 | 5 | SM00028 | |
| Domain | AAA | 1.06e-03 | 144 | 100 | 5 | SM00382 | |
| Domain | AAA+_ATPase | 1.06e-03 | 144 | 100 | 5 | IPR003593 | |
| Domain | STI1 | 1.24e-03 | 10 | 100 | 2 | SM00727 | |
| Domain | STI1_HS-bd | 1.24e-03 | 10 | 100 | 2 | IPR006636 | |
| Domain | TPR-contain_dom | 1.28e-03 | 150 | 100 | 5 | IPR013026 | |
| Domain | TPR_1 | 1.39e-03 | 90 | 100 | 4 | IPR001440 | |
| Domain | TPR_1 | 1.39e-03 | 90 | 100 | 4 | PF00515 | |
| Domain | P-loop_NTPase | SAMD9 ABCF3 CENPE NAIP DNAH2 MYO18A RFC1 DHX8 ARFRP1 ABCA6 ASPM RAB7A | 1.90e-03 | 848 | 100 | 12 | IPR027417 |
| Domain | P_typ_ATPase_c | 2.48e-03 | 14 | 100 | 2 | IPR032630 | |
| Domain | P-type_ATPase_N | 2.48e-03 | 14 | 100 | 2 | IPR032631 | |
| Domain | P-type_ATPase_IV | 2.48e-03 | 14 | 100 | 2 | IPR006539 | |
| Domain | ATP_GRASP | 2.48e-03 | 14 | 100 | 2 | PS50975 | |
| Domain | ATP-grasp | 2.48e-03 | 14 | 100 | 2 | IPR011761 | |
| Domain | PhoLip_ATPase_C | 2.48e-03 | 14 | 100 | 2 | PF16212 | |
| Domain | PhoLip_ATPase_N | 2.48e-03 | 14 | 100 | 2 | PF16209 | |
| Domain | - | 2.85e-03 | 15 | 100 | 2 | 3.30.1490.20 | |
| Domain | ATP_grasp_subdomain_1 | 4.11e-03 | 18 | 100 | 2 | IPR013815 | |
| Domain | - | 4.11e-03 | 18 | 100 | 2 | 3.30.470.20 | |
| Domain | Myosin-like_IQ_dom | 4.57e-03 | 19 | 100 | 2 | IPR027401 | |
| Domain | - | 4.57e-03 | 19 | 100 | 2 | 4.10.270.10 | |
| Domain | CH | 5.12e-03 | 65 | 100 | 3 | SM00033 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | ACACA PSMA4 UGGT1 SH3GL1 MYO18A SPART PSMD11 RFC1 PREPL ST13 SF3B3 DST NUFIP2 SUPT16H RAB7A ATIC CACYBP PATJ ANAPC7 HSPA4 | 1.56e-10 | 1149 | 103 | 20 | 35446349 |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | ABCF3 ACACA PSMA4 UGGT1 SH3GL1 MYO18A SPART PSMD11 RFC1 SUCLG2 ST13 SF3B3 MTOR SYNE2 SUPT16H RAB7A ATIC CACYBP HSPA4 LRRFIP1 | 3.11e-09 | 1367 | 103 | 20 | 32687490 |
| Pubmed | ACACA PSMA4 UGGT1 SPART PSMD11 RFC1 BPTF DST TMTC3 SYNE2 NUFIP2 MLH1 RAB7A GMFB ATP11A UQCRC2 CACYBP ST13P5 HSPA4 | 7.99e-09 | 1297 | 103 | 19 | 33545068 | |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | ACACA ST13 DHX8 SF3B3 DST NUFIP2 SUPT16H ATIC UQCRC2 CACYBP HSPA4 LRRFIP1 | 1.91e-08 | 477 | 103 | 12 | 31300519 |
| Pubmed | ABCF3 ACACA NEBL PSMA4 SH3GL1 PSMD11 RFC1 DHX8 EIF2D SF3B3 NUFIP2 MLH1 RAB7A ATIC CACYBP PATJ HSPA4 | 1.50e-07 | 1247 | 103 | 17 | 27684187 | |
| Pubmed | UGGT1 DNAH2 MYO18A NEB BPTF SF3B3 DST IFT88 SYNE2 SUPT16H ASPM ATP11C ATP11A UQCRC2 ANAPC7 SLC25A31 CFAP46 ZNF292 | 2.28e-07 | 1442 | 103 | 18 | 35575683 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | ABCF3 ACACA SH3GL1 MYO18A SPART DHX8 SF3B3 NUFIP2 UQCRC2 CACYBP ANAPC7 LRRFIP1 ZNF292 | 2.38e-07 | 724 | 103 | 13 | 36232890 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | ABCF3 ACACA PSMA4 PSMD11 RFC1 SUCLG2 EIF2D SF3B3 DST RPTOR SUPT16H ASPM MLH1 RAB7A ATIC UQCRC2 HSPA4 | 4.71e-07 | 1353 | 103 | 17 | 29467282 |
| Pubmed | 5.01e-07 | 6 | 103 | 3 | 16962653 | ||
| Pubmed | ACACA UGGT1 RFC1 DHX8 BPTF DST MTOR SYNE2 NUFIP2 ATIC UQCRC2 HSPA4 | 5.60e-07 | 653 | 103 | 12 | 22586326 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | ACACA PSMA4 UGGT1 PSMD11 RFC1 ST13 DHX8 SF3B3 MTOR RPTOR SUPT16H RAB7A ATIC UQCRC2 CACYBP ANAPC7 HSPA4 | 9.62e-07 | 1425 | 103 | 17 | 30948266 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | MTMR12 ACACA SH3GL1 FSIP2 DST MTOR RPTOR SYNE2 AKAP11 NUB1 PATJ PIBF1 ARHGAP19 | 1.65e-06 | 861 | 103 | 13 | 36931259 |
| Pubmed | ERO1B UGGT1 MYO18A SPART PREPL ST13 SF3B3 TMTC3 SYNE2 SUPT16H ASPM RAB7A AKAP11 UQCRC2 CACYBP PIBF1 HSPA4 | 1.72e-06 | 1487 | 103 | 17 | 33957083 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | CHAF1B UGGT1 PSMD11 DHX8 BPTF SF3B3 DST SYNE2 SUPT16H RAB7A ATIC UQCRC2 ANAPC7 HSPA4 | 2.03e-06 | 1024 | 103 | 14 | 24711643 |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 2.48e-06 | 202 | 103 | 7 | 33005030 | |
| Pubmed | Hsp70 associates with Rictor and is required for mTORC2 formation and activity. | 2.98e-06 | 10 | 103 | 3 | 18505677 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | ACACA NEBL PSMA4 SH3GL1 RNF113A SPART RFC1 DST NUFIP2 MLH1 ATIC CACYBP HSPA4 | 4.01e-06 | 934 | 103 | 13 | 33916271 |
| Pubmed | Expression QTL and regulatory network analysis of microtubule-associated protein tau gene. | 4.09e-06 | 11 | 103 | 3 | 19233709 | |
| Pubmed | A Role for Mitochondrial Translation in Promotion of Viability in K-Ras Mutant Cells. | 4.54e-06 | 419 | 103 | 9 | 28700943 | |
| Pubmed | CHAF1B PSMA4 UGGT1 SH3GL1 PSMD11 RFC1 SUCLG2 ST13 SF3B3 DST MTOR SYNE2 SUPT16H UQCRC2 HSPA4 LRRFIP1 | 5.15e-06 | 1440 | 103 | 16 | 30833792 | |
| Pubmed | 6.53e-06 | 234 | 103 | 7 | 36243803 | ||
| Pubmed | mTORC1 phosphorylates UVRAG to negatively regulate autophagosome and endosome maturation. | 7.06e-06 | 13 | 103 | 3 | 25533187 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 30202948 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 18270303 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 27649073 | ||
| Pubmed | mTORC2, but not mTORC1, is required for hippocampal mGluR-LTD and associated behaviors. | 8.69e-06 | 2 | 103 | 2 | 29786082 | |
| Pubmed | Activation of mTORC1 is essential for β-adrenergic stimulation of adipose browning. | 8.69e-06 | 2 | 103 | 2 | 27018708 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 16847060 | ||
| Pubmed | SF3B3-regulated mTOR alternative splicing promotes colorectal cancer progression and metastasis. | 8.69e-06 | 2 | 103 | 2 | 38671459 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 19851499 | ||
| Pubmed | St13 protects against disordered acinar cell arachidonic acid pathway in chronic pancreatitis. | 8.69e-06 | 2 | 103 | 2 | 35562743 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 25486193 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 17301289 | ||
| Pubmed | Conditional Knockout of Raptor/mTORC1 Results in Dentin Malformation. | 8.69e-06 | 2 | 103 | 2 | 30984011 | |
| Pubmed | Hepatic peroxisomal β-oxidation suppresses lipophagy via RPTOR acetylation and MTOR activation. | 8.69e-06 | 2 | 103 | 2 | 32687428 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 15533723 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 20439490 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 36162506 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | CHAF1B RFC1 DHX8 FSIP2 PWWP2A BPTF SUPT16H MLH1 ANAPC7 ZNF292 | 1.36e-05 | 608 | 103 | 10 | 36089195 |
| Pubmed | MKRN3 PPP1R21 CHAF1B ACACA DNAH2 MYO18A SYNE2 NUFIP2 RAB7A CACYBP ANAPC7 | 1.51e-05 | 754 | 103 | 11 | 35906200 | |
| Pubmed | 1.69e-05 | 494 | 103 | 9 | 26831064 | ||
| Pubmed | 1.77e-05 | 497 | 103 | 9 | 23414517 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | CHAF1B ACACA MYO18A RFC1 BPTF EIF2D RPTOR TAOK1 ELK3 LRRFIP1 SOS1 | 1.92e-05 | 774 | 103 | 11 | 15302935 |
| Pubmed | Targeting the interaction of AIMP2-DX2 with HSP70 suppresses cancer development. | 2.05e-05 | 54 | 103 | 4 | 31792442 | |
| Pubmed | Tel2 structure and function in the Hsp90-dependent maturation of mTOR and ATR complexes. | 2.36e-05 | 19 | 103 | 3 | 20801936 | |
| Pubmed | 2.50e-05 | 288 | 103 | 7 | 23383273 | ||
| Pubmed | 2.57e-05 | 399 | 103 | 8 | 37536630 | ||
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 23440873 | ||
| Pubmed | mTOR kinase inhibitors promote antibody class switching via mTORC2 inhibition. | 2.60e-05 | 3 | 103 | 2 | 25385646 | |
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 28813526 | ||
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 28283069 | ||
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 17656678 | ||
| Pubmed | Muscle inactivation of mTOR causes metabolic and dystrophin defects leading to severe myopathy. | 2.60e-05 | 3 | 103 | 2 | 20008564 | |
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 22356909 | ||
| Pubmed | PARP14 correlates with GBM proliferation and poor prognosis by elevating expression of SAMD/SAMD9L. | 2.60e-05 | 3 | 103 | 2 | 37612499 | |
| Pubmed | mTORC1 directly phosphorylates and activates ERα upon estrogen stimulation. | 2.60e-05 | 3 | 103 | 2 | 26522726 | |
| Pubmed | Leucine regulates autophagy via acetylation of the mTORC1 component raptor. | 2.60e-05 | 3 | 103 | 2 | 32561715 | |
| Pubmed | Regulation of mTOR complex 1 (mTORC1) by raptor Ser863 and multisite phosphorylation. | 2.60e-05 | 3 | 103 | 2 | 19864431 | |
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 24567410 | ||
| Pubmed | mTOR has distinct functions in generating versus sustaining humoral immunity. | 2.60e-05 | 3 | 103 | 2 | 27760048 | |
| Pubmed | Essential role of D1R in the regulation of mTOR complex1 signaling induced by cocaine. | 2.60e-05 | 3 | 103 | 2 | 26314207 | |
| Pubmed | Genetic variations of mTORC1 genes and risk of gastric cancer in an Eastern Chinese population. | 2.60e-05 | 3 | 103 | 2 | 23423739 | |
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 23966835 | ||
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 26678875 | ||
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 19145465 | ||
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 20233713 | ||
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 21471201 | ||
| Pubmed | The Potential Role of BRCA1-Associated ATM Activator-1 (BRAT1) in Regulation of mTOR. | 2.60e-05 | 3 | 103 | 2 | 25657994 | |
| Pubmed | Expression of the mTOR pathway regulators in human pituitary adenomas indicates the clinical course. | 2.60e-05 | 3 | 103 | 2 | 23898069 | |
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 12912989 | ||
| Pubmed | Localization of Rheb to the endomembrane is critical for its signaling function. | 2.60e-05 | 3 | 103 | 2 | 16631613 | |
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 22143799 | ||
| Pubmed | Involvement of mTORC1 and mTORC2 in regulation of glioblastoma multiforme growth and motility. | 2.60e-05 | 3 | 103 | 2 | 19724909 | |
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 27521345 | ||
| Pubmed | mTORC1 Signaling is a Critical Regulator of Postnatal Tendon Development. | 2.60e-05 | 3 | 103 | 2 | 29215029 | |
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 18614546 | ||
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 27342766 | ||
| Pubmed | Parkin ubiquitinates mTOR to regulate mTORC1 activity under mitochondrial stress. | 2.60e-05 | 3 | 103 | 2 | 25007995 | |
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 22504639 | ||
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 23541542 | ||
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 12408816 | ||
| Pubmed | GSK3-mediated raptor phosphorylation supports amino-acid-dependent mTORC1-directed signalling. | 2.60e-05 | 3 | 103 | 2 | 26348909 | |
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 25849663 | ||
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 26683665 | ||
| Pubmed | Reconstitution of leucine-mediated autophagy via the mTORC1-Barkor pathway in vitro. | 2.60e-05 | 3 | 103 | 2 | 22258093 | |
| Pubmed | TOS motif-mediated raptor binding regulates 4E-BP1 multisite phosphorylation and function. | 2.60e-05 | 3 | 103 | 2 | 12747827 | |
| Pubmed | Langerhans cell homeostasis in mice is dependent on mTORC1 but not mTORC2 function. | 2.60e-05 | 3 | 103 | 2 | 23212520 | |
| Pubmed | mTORC1 maintains renal tubular homeostasis and is essential in response to ischemic stress. | 2.60e-05 | 3 | 103 | 2 | 24958889 | |
| Pubmed | Hexokinase-II positively regulates glucose starvation-induced autophagy through TORC1 inhibition. | 2.60e-05 | 3 | 103 | 2 | 24462113 | |
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 17041623 | ||
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 25906254 | ||
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 28686577 | ||
| Pubmed | VHL suppresses RAPTOR and inhibits mTORC1 signaling in clear cell renal cell carcinoma. | 2.60e-05 | 3 | 103 | 2 | 34290272 | |
| Pubmed | MKRN3 CHAF1B ADAM23 WHAMM VPS54 PREPL ST13 DST IFT88 TAOK1 ATIC LRRFIP1 ZNF292 SOS1 | 2.64e-05 | 1285 | 103 | 14 | 35914814 | |
| Pubmed | Identification of Protor as a novel Rictor-binding component of mTOR complex-2. | 2.77e-05 | 20 | 103 | 3 | 17461779 | |
| Pubmed | CHAF1B PSMA4 PSMD11 RFC1 ST13 SF3B3 NUFIP2 ASPM UNC13C CACYBP ANAPC7 HSPA4 | 3.12e-05 | 971 | 103 | 12 | 33306668 | |
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | 3.19e-05 | 536 | 103 | 9 | 15840001 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | MTMR12 PSMA4 UGGT1 SH3GL1 PSMD11 PREPL TMTC3 MTOR RAB7A UQCRC2 CACYBP HSPA4 | 3.21e-05 | 974 | 103 | 12 | 28675297 |
| Pubmed | 3.28e-05 | 538 | 103 | 9 | 10512203 | ||
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | CENPE PSMD11 SUCLG2 PREPL ST13 ELOVL2 DST RPTOR SYNE2 SUPT16H RAB7A AKAP11 UQCRC2 CACYBP ANAPC7 | 3.46e-05 | 1496 | 103 | 15 | 32877691 |
| Interaction | TXNDC2 interactions | 1.46e-06 | 17 | 103 | 4 | int:TXNDC2 | |
| Interaction | BAP1 interactions | ACACA PSMA4 UGGT1 SH3GL1 MYO18A SPART PSMD11 RFC1 PREPL ST13 SF3B3 DST NUFIP2 SUPT16H RAB7A ELK3 ATIC CACYBP PATJ ANAPC7 HSPA4 | 2.52e-06 | 1314 | 103 | 21 | int:BAP1 |
| Interaction | PINK1 interactions | ACACA PSMD11 ST13 DHX8 SF3B3 DST NUFIP2 SUPT16H ATIC UQCRC2 CACYBP HSPA4 SLC25A31 LRRFIP1 | 9.17e-06 | 679 | 103 | 14 | int:PINK1 |
| Interaction | PDLIM5 interactions | ARHGAP15 PSMA4 SH3GL1 PSMD11 ST13 SYNE2 CACYBP ARHGAP19 SOS1 | 1.11e-05 | 273 | 103 | 9 | int:PDLIM5 |
| Cytoband | 17q11.2 | 1.15e-04 | 110 | 103 | 4 | 17q11.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q11 | 6.17e-04 | 171 | 103 | 4 | chr17q11 | |
| Cytoband | 17q24.3 | 6.63e-04 | 17 | 103 | 2 | 17q24.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q24 | 1.43e-03 | 98 | 103 | 3 | chr17q24 | |
| Cytoband | 3q13.2 | 2.22e-03 | 31 | 103 | 2 | 3q13.2 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 8.89e-05 | 115 | 71 | 5 | 769 | |
| GeneFamily | MTOR complex 1|MTOR complex 2 | 9.08e-05 | 4 | 71 | 2 | 1332 | |
| GeneFamily | ATPase phospholipid transporting | 1.54e-03 | 15 | 71 | 2 | 1210 | |
| GeneFamily | Dyneins, axonemal | 1.99e-03 | 17 | 71 | 2 | 536 | |
| GeneFamily | Intraflagellar transport proteins|Tetratricopeptide repeat domain containing | 3.97e-03 | 24 | 71 | 2 | 615 | |
| GeneFamily | ETS transcription factor family | 5.38e-03 | 28 | 71 | 2 | 534 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 5.60e-03 | 181 | 71 | 4 | 694 | |
| Coexpression | KIM_MYC_AMPLIFICATION_TARGETS_DN | 2.50e-06 | 98 | 103 | 6 | M6319 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | COL5A2 CENPE SPART ELOVL2 SNX13 BPTF DST SYNE2 AKAP11 PIBF1 LRRFIP1 ARHGAP19 ZNF292 SOS1 | 6.57e-06 | 856 | 103 | 14 | M4500 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | CENPE ZNF268 PSMA4 ZNF407 FPGT RFC1 SNX13 BPTF SYNE2 ASPM AKAP11 PIBF1 | 1.05e-05 | 656 | 103 | 12 | M18979 |
| Coexpression | GSE17721_CTRL_VS_CPG_6H_BMDC_DN | 1.45e-05 | 200 | 103 | 7 | M3765 | |
| Coexpression | HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_3DY_NEGATIVE | ANGPT2 UGGT1 MYO18A CCDC167 PREPL PWWP2A SF3B3 ARFRP1 CXCR6 MLH1 ANAPC7 | 4.23e-05 | 637 | 103 | 11 | M41118 |
| Coexpression | MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN | COL5A2 SPART ST13 NUFIP2 SUPT16H RAB7A TMPRSS2 ATP11C ATIC ST13P5 | 5.64e-05 | 543 | 103 | 10 | MM997 |
| Coexpression | KIM_ALL_DISORDERS_CALB1_CORR_UP | ABCF3 HTR2A ADAM23 PSMA4 PSMD11 PREPL GMFB AKAP11 ATIC UQCRC2 | 6.00e-05 | 547 | 103 | 10 | M2110 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 1.48e-05 | 298 | 103 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 2.08e-05 | 311 | 103 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 4.22e-05 | 192 | 103 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.68e-07 | 176 | 102 | 7 | 3bbac5c2397535631fce8fa98f6ddb4fe0260351 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 2.19e-07 | 183 | 102 | 7 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 3.86e-07 | 199 | 102 | 7 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.99e-07 | 200 | 102 | 7 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.19e-06 | 148 | 102 | 6 | d61123f0c811287843d066b932b4a9ff09c07c5b | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Ciliated_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.19e-06 | 148 | 102 | 6 | c8e93b87212f55774223caa385859c566fa1981f | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.56e-06 | 155 | 102 | 6 | 5f1e2195a6b831e1b636f5cc3a282ca423721822 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.56e-06 | 155 | 102 | 6 | 0944429459f642a1bcc56edc1ec28aaecde3e2dc | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 4.74e-06 | 188 | 102 | 6 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.74e-06 | 188 | 102 | 6 | af740fa78542438fdff627ea1f74f4eee43316be | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.19e-06 | 191 | 102 | 6 | a0332a4ef629510fb313ec119195c44a3f704a80 | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.19e-06 | 191 | 102 | 6 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 5.35e-06 | 192 | 102 | 6 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2|World / Lineage, Cell type, age group and donor | 5.35e-06 | 192 | 102 | 6 | 58c3737be7acce39fd2b91d70d6d7b2bbaa4f710 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 5.35e-06 | 192 | 102 | 6 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.68e-06 | 194 | 102 | 6 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.68e-06 | 194 | 102 | 6 | b0477583301dc6d9767b667bd2f8f94fbfaa6f81 | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.85e-06 | 195 | 102 | 6 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | (08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition | 1.66e-05 | 138 | 102 | 5 | 817e3f639604ea95adae01e8685ffaa2e0aff7a8 | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Ciliated_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.55e-05 | 151 | 102 | 5 | 81cf939ed4df9574fbfff265e109cb9f947d7e6e | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.55e-05 | 151 | 102 | 5 | 9cbcbbc22965a9f0be8364e733d205dd64f2a533 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells-Ciliated|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.81e-05 | 154 | 102 | 5 | 4e3bc24043144143842627cacf6f90dda2228910 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.81e-05 | 154 | 102 | 5 | 7556a4b2b062da5ae7ec2bbb66e745e7662db628 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.58e-05 | 162 | 102 | 5 | ec29c6f1c31e41ddcb041a49c593910edaf0532c | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.68e-05 | 163 | 102 | 5 | 7864e966c228282b4b63c43164dba3faba21026d | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.37e-05 | 169 | 102 | 5 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D231|Adult / Lineage, Cell type, age group and donor | 4.50e-05 | 170 | 102 | 5 | 269dee5abca9f6aa079f116f0d8f1d198604d9d4 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.50e-05 | 170 | 102 | 5 | a2c738e441ced90eeeb1fcc6ca3269b918aaa298 | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.02e-05 | 174 | 102 | 5 | 9d5dcd46cf346c381dea68ada6665f7fb68114a3 | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.02e-05 | 174 | 102 | 5 | 53cec5c666c45278a71c21dd9c62a052a97e0fdf | |
| ToppCell | RSV-Healthy-1|Healthy / Virus stimulation, Condition and Cluster | 5.16e-05 | 175 | 102 | 5 | ff3a27f512a3a710ebc863b7b75cce8167d5440b | |
| ToppCell | RSV-Healthy-1|RSV / Virus stimulation, Condition and Cluster | 5.16e-05 | 175 | 102 | 5 | ca52b99b03535a5b3a2751d6981708dc5b255b91 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.30e-05 | 176 | 102 | 5 | 27c5ddd67de52101360ef7de8fcfa041066d97db | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.60e-05 | 178 | 102 | 5 | fcbbcc44271515de1969b4732b6441c012693d5f | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.75e-05 | 179 | 102 | 5 | 5e5f1cdf4aa66868d45b74ba91e20e848a3cbaff | |
| ToppCell | 5'-Adult-LymphNode-Epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.90e-05 | 180 | 102 | 5 | cc974ac352ef2adc953fb5f325880e5857595889 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D122|Adult / Lineage, Cell type, age group and donor | 6.22e-05 | 182 | 102 | 5 | 7ded554a4b441e6496db673ba206c0d76ccad7d9 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Deuterosomal|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.22e-05 | 182 | 102 | 5 | 000eca5baa6eb2335a1e6d76a13fff5382b0e150 | |
| ToppCell | Mild-CD4+_T|World / Disease group and Cell class | 6.38e-05 | 183 | 102 | 5 | c4ac8893d38a3da4e19fe2ef1756bd69c89e975c | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.38e-05 | 183 | 102 | 5 | 6847c1252d6bb105524f812658112517fd351eab | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.55e-05 | 184 | 102 | 5 | 42ce855b4f8475a8298192feec785bdc69bc5bb0 | |
| ToppCell | COVID-19-Epithelial_cells-AT2|COVID-19 / group, cell type (main and fine annotations) | 6.55e-05 | 184 | 102 | 5 | 369b82f793deab672204558ae4e112cfa5aa9ccc | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Adult / Lineage, Cell type, age group and donor | 6.72e-05 | 185 | 102 | 5 | 673f0c688ae6984bc8027df2da335787924f4137 | |
| ToppCell | 15-Airway-Epithelial-Multiciliated_cell|Airway / Age, Tissue, Lineage and Cell class | 6.72e-05 | 185 | 102 | 5 | 0998b6bf44287eebbf39249fff23fc3689e44c4e | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.72e-05 | 185 | 102 | 5 | 3e39a3cb534dfe2301930f3e2f7e8cefb522c158 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-F_(Ciliated)|390C / Donor, Lineage, Cell class and subclass (all cells) | 6.89e-05 | 186 | 102 | 5 | 708c5edefe36c91df27cf53c1b5101fb2030cc5a | |
| ToppCell | 390C-Epithelial_cells-Epithelial-F_(Ciliated)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 6.89e-05 | 186 | 102 | 5 | 029390c4aaf64e6bcd86124cd4a6dd2e6f3a374b | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.89e-05 | 186 | 102 | 5 | f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0 | |
| ToppCell | Control-Lymphocyte-T_NK-CD4_TCM|Control / Disease, Lineage and Cell Type | 7.07e-05 | 187 | 102 | 5 | 1de80f40f753b31aed1fac9f3ff8a2ee6c755eec | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.07e-05 | 187 | 102 | 5 | c31130fc2f9f882944b2ba366a034a03f051c4b9 | |
| ToppCell | COVID-19-Heart-EC_2|Heart / Disease (COVID-19 only), tissue and cell type | 7.07e-05 | 187 | 102 | 5 | 40ffc06a3e3251d9b12da390210d3e045af7537a | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.07e-05 | 187 | 102 | 5 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.07e-05 | 187 | 102 | 5 | 9e10ed56090d82589bc457788282f664b70ace4b | |
| ToppCell | Epithelial-ciliated_cell|World / Lineage, Cell type, age group and donor | 7.25e-05 | 188 | 102 | 5 | 61a459f3fe57e5728efc72637ff2edc2d343492b | |
| ToppCell | Adult-Epithelial-ciliated_cell-D231|Adult / Lineage, Cell type, age group and donor | 7.25e-05 | 188 | 102 | 5 | 34b11f72ca73153d02edcd09b38983ad1a504659 | |
| ToppCell | COPD-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 7.25e-05 | 188 | 102 | 5 | 186fe1ea328c942910190a4240262c0d8642ea3b | |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 7.25e-05 | 188 | 102 | 5 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | COVID-19-lung-Ciliated|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.43e-05 | 189 | 102 | 5 | a2da5debd10f27b1280b40141ef0bfef007cc72c | |
| ToppCell | Adult-Epithelial-ciliated_cell|Adult / Lineage, Cell type, age group and donor | 7.43e-05 | 189 | 102 | 5 | b679920f0993e917dd86da082113bfbd85ea1ca5 | |
| ToppCell | COVID-19-lung-Ciliated|lung / Disease (COVID-19 only), tissue and cell type | 7.43e-05 | 189 | 102 | 5 | 27329c4661aebabd19fac7fe5dca263fe99d76f3 | |
| ToppCell | Ciliated|World / shred by cell class for parenchyma | 7.43e-05 | 189 | 102 | 5 | 711181ca3b9102fb155168b646b0a9b09ff215b2 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-F_(Ciliated)|343B / Donor, Lineage, Cell class and subclass (all cells) | 7.62e-05 | 190 | 102 | 5 | 169e600e95878000acf5d11f813f9028c7249646 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-F_(Ciliated)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 7.62e-05 | 190 | 102 | 5 | 0cc36117c793d83cf4a1f66f47758a07d6712bd3 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.81e-05 | 191 | 102 | 5 | d9a6f61fcda4f5352488f7f55cb9b57aeacc717f | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.81e-05 | 191 | 102 | 5 | f76f3f5c7902a3659d8cbe470f96ce57c8a6744d | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.81e-05 | 191 | 102 | 5 | e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|World / Lineage, Cell type, age group and donor | 7.81e-05 | 191 | 102 | 5 | d3733c8c4bda70c4390e5601fdda6188a64be944 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.81e-05 | 191 | 102 | 5 | 9d31c8424d35bdc0c27188b68bfd0f731af3600b | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-MUC16+_ciliated|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 7.81e-05 | 191 | 102 | 5 | e81cd65dbf0ef1c2ab7088f73ce605d456dd3a7a | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.81e-05 | 191 | 102 | 5 | 1c528f72c9ef3ef3a850b05e4a9715190832270c | |
| ToppCell | Control-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 8.00e-05 | 192 | 102 | 5 | 1bfd022d5b87cf8a5d5069f559339a553a52a0a2 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.00e-05 | 192 | 102 | 5 | 5b7093d5af5ae7b0e6d3a464cc56272440ecedad | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 8.00e-05 | 192 | 102 | 5 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | COPD-Epithelial|COPD / Disease state, Lineage and Cell class | 8.00e-05 | 192 | 102 | 5 | 0644fad5df18f0021f6f49cca996d8cf47f972ff | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.20e-05 | 193 | 102 | 5 | 2901d7a9672a8cf70c9f1c752685b45e4d79ac70 | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 8.20e-05 | 193 | 102 | 5 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.20e-05 | 193 | 102 | 5 | f4310faa13fc8ce99a217e2d1c9cc733683797a1 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 8.20e-05 | 193 | 102 | 5 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | ICU-NoSEP-Lymphocyte-T_NK-CD8_Naive|ICU-NoSEP / Disease, Lineage and Cell Type | 8.20e-05 | 193 | 102 | 5 | c2bc6656c3dd8b05ae9336653e744671f11c9c4f | |
| ToppCell | Healthy-CD4+_Tcm|Healthy / disease group, cell group and cell class | 8.40e-05 | 194 | 102 | 5 | 85c2c4f6b87a50b67903770a2dc74da765757c6d | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.40e-05 | 194 | 102 | 5 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4|GI_small-bowel / Manually curated celltypes from each tissue | 8.40e-05 | 194 | 102 | 5 | 4547b57669be5d4f0de55175802ee04372288a6a | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)|390C / Donor, Lineage, Cell class and subclass (all cells) | 8.40e-05 | 194 | 102 | 5 | 88db9f9e80c20ff3474f1f6459dcbdc25aec0b6d | |
| ToppCell | ASK452-Epithelial-Ciliated|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 8.40e-05 | 194 | 102 | 5 | 5aeb44657ab6f61b1abf98af28d3397d8e44c1aa | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 8.40e-05 | 194 | 102 | 5 | a71728202493d4858342ea2756ea281cd0d99a3a | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.40e-05 | 194 | 102 | 5 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | Control-Multiplet|Control / Disease state, Lineage and Cell class | 8.61e-05 | 195 | 102 | 5 | 618900c80bea09d46dad3f741bd1bff8bf0a64ee | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.61e-05 | 195 | 102 | 5 | c1435e61e4f0cf457f26ae436936048932ceb0db | |
| ToppCell | Control-Multiplet-Multiplet|Control / Disease state, Lineage and Cell class | 8.61e-05 | 195 | 102 | 5 | 06ac685855e14e4dd2cbe6d0e73f894f2eeff91f | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.82e-05 | 196 | 102 | 5 | 9afd0a7135028a446f06bb68f334e79b8f171b45 | |
| ToppCell | critical-Epithelial-Ciliated|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.82e-05 | 196 | 102 | 5 | 27b855c6e1ae44f16db998cf0e81bd686b9cee7e | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 8.82e-05 | 196 | 102 | 5 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | severe-T/NK_proliferative|severe / disease stage, cell group and cell class | 8.82e-05 | 196 | 102 | 5 | 89f005216770dbb84378f5d1f20ca11b0ce40faa | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Ciliated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.82e-05 | 196 | 102 | 5 | 686a5a0ddb00929842c1c98445c59edfcc9a8a04 | |
| ToppCell | Healthy-CD4+_Tcm|World / disease group, cell group and cell class | 8.82e-05 | 196 | 102 | 5 | cf19bc920f3ef07a87a2cdcb43f9f5855ef1fa9a | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Ciliated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.82e-05 | 196 | 102 | 5 | 67aefc480714e4b8c9ae53c036efdc07ec6f94af | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Ciliated|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.82e-05 | 196 | 102 | 5 | ca56311edc6788e032e7635fa69b1e07035202b5 | |
| ToppCell | Severe_COVID-19-Epithelial-Ciliated|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 8.82e-05 | 196 | 102 | 5 | 1cdef976a754c90d18b6149d367bd64e6e99b0a9 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 8.82e-05 | 196 | 102 | 5 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | IPF-Epithelial|IPF / Disease state, Lineage and Cell class | 8.82e-05 | 196 | 102 | 5 | 87d9881cfec461a5d89b688a83749b618c519485 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.75e-04 | 49 | 62 | 4 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.89e-04 | 50 | 62 | 4 | GAVISH_3CA_METAPROGRAM_B_CELLS_B_CELLS_1 | |
| Disease | high grade glioma (is_marker_for) | 1.42e-05 | 42 | 103 | 4 | DOID:3070 (is_marker_for) | |
| Disease | Intellectual Disability | 1.76e-04 | 447 | 103 | 8 | C3714756 | |
| Disease | Developmental delay (disorder) | 2.94e-04 | 37 | 103 | 3 | C0424605 | |
| Disease | transverse temporal cortex volume measurement | 5.33e-04 | 10 | 103 | 2 | EFO_0010336 | |
| Disease | obsolete_red blood cell distribution width | SAMD9 SH3GL1 PKD2L1 ZNF407 RFC1 SNX13 ABCA6 SYNE2 NUFIP2 ATP11C TAOK1 ATP11A PIBF1 | 8.30e-04 | 1347 | 103 | 13 | EFO_0005192 |
| Disease | autosomal dominant polycystic kidney disease (implicated_via_orthology) | 1.07e-03 | 14 | 103 | 2 | DOID:898 (implicated_via_orthology) | |
| Disease | Autosomal recessive primary microcephaly | 1.23e-03 | 15 | 103 | 2 | cv:C3711387 | |
| Disease | Global developmental delay | 1.24e-03 | 133 | 103 | 4 | C0557874 | |
| Disease | autosomal recessive polycystic kidney disease (implicated_via_orthology) | 1.40e-03 | 16 | 103 | 2 | DOID:0110861 (implicated_via_orthology) | |
| Disease | portal hypertension (implicated_via_orthology) | 1.99e-03 | 19 | 103 | 2 | DOID:10762 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | 3.23e-03 | 702 | 103 | 8 | C0009402 | |
| Disease | Ataxia | 3.44e-03 | 25 | 103 | 2 | C0004134 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MVYFGKNQSLQKIQK | 626 | Q13075 | |
| TDLKTFMGKAQNQKY | 421 | Q96MC4 | |
| KSSYKKLSKFLQQMQ | 311 | P41214 | |
| KTLAGQYSKQMKNLT | 251 | O75077 | |
| VVKATKAYNQQAKRM | 131 | O00574 | |
| AGHSNKYLKMANNTK | 111 | Q86YB8 | |
| MNMKQKSVYQQTKAL | 1 | Q8N139 | |
| YNANRASQVQSKLKM | 446 | Q9NUQ8 | |
| ALAYKSSQLQMGQKK | 416 | P28223 | |
| NFRKSMDSIGKKQYQ | 21 | O15123 | |
| NVMNTTYVFSRKNLK | 261 | Q13112 | |
| KEKNYGQAKKMIAQA | 1651 | Q8IYW2 | |
| KSIKKEMAQYASNIT | 916 | Q13085 | |
| SQVKTNKELLMFSNK | 1401 | Q9UKA4 | |
| GQKKKNSNMTYEKLS | 316 | P78545 | |
| KAKTQPAVKNMYRSA | 441 | Q8IV53 | |
| TKKEVIMKGNINNYF | 826 | Q12830 | |
| QSTVKMKQTRKQYLH | 1686 | Q8IZT6 | |
| SVLKQNKSNSAYKEM | 326 | Q8IWA6 | |
| SKYQSNPKVMNLISK | 346 | Q8NFI4 | |
| SKYQSNPKVMNLISK | 346 | P50502 | |
| VQAAKNKLKAGYLMS | 371 | P22695 | |
| KTSLMNQYVNKKFSN | 21 | P51149 | |
| MAQKKYLQAKLTQFL | 1 | Q9Y5A7 | |
| NAVSKYTMALQQKKA | 61 | Q9UJX3 | |
| TKNQEIKSKTYQVMR | 31 | Q8IVN3 | |
| IQQYMKIISSFKNKE | 706 | P34932 | |
| ERTKGNMKYKAVSVN | 216 | Q9C0I1 | |
| YSNKYLTMLQTQQKS | 5096 | Q03001 | |
| KYGNKKQSMISAKDI | 4846 | Q5CZC0 | |
| SDKQNQAKLYDTAMK | 5816 | Q5CZC0 | |
| QKAAQQFSKLQAAMK | 636 | Q92614 | |
| LVKNLNGKSYSMIVN | 116 | Q9HB71 | |
| VQYQMQFSKAKSASK | 496 | Q8N4P6 | |
| NYFTNIQMEKAKRKT | 341 | P48169 | |
| MASAELQGKYQKLAQ | 1 | Q6ZMI0 | |
| MIQKTRDSGKQKAAY | 66 | O15541 | |
| KEKNSLMNKASNYEK | 51 | Q9P0B6 | |
| KNLNTKLQMYFQSPK | 21 | Q460N5 | |
| KYKQLFMSGVNKEKQ | 106 | Q9H0C2 | |
| QSKTRFNKNYKGMSL | 36 | Q13795 | |
| KEIFTTNNGYKSMQK | 16 | Q9Y366 | |
| TNNGYKSMQKKLRSN | 21 | Q9Y366 | |
| ALNTYQVIVKNKMFS | 216 | Q13099 | |
| PYKSLNKQQKSISAM | 1231 | Q9UFH2 | |
| KAYFTAANGVMNKKA | 281 | Q9NXB9 | |
| VTLNFNKKEIQKGYM | 106 | Q2WGN9 | |
| KNSVGYMDDQAKNLK | 1406 | P05997 | |
| GLRKNKTNMNYDKLS | 46 | P41970 | |
| SIVKAQVSKKQYNMN | 931 | Q8IY85 | |
| VMKKNQVSILNKYSE | 1681 | Q9P225 | |
| NNSAAAVSMLKQDYK | 166 | P25789 | |
| GKINKMKNSNYADQF | 426 | Q02224 | |
| KMLNAVKNKSAFSLN | 556 | O14772 | |
| NKASYGKKTQMSILE | 546 | Q14562 | |
| YKKAMVSNAQLDNEK | 171 | Q32MZ4 | |
| MTQNKLKLCSKANVY | 1 | O15403 | |
| RKYMKSGNVKDLTQA | 2086 | P42345 | |
| QMMYAGSKNKLVQTA | 101 | P60983 | |
| RSKQMQKYKQKLQTT | 946 | Q9Y5W8 | |
| KNNISVYMTLNQKKS | 561 | Q96N64 | |
| QVCKNLQFYLNKMKT | 1596 | Q8WXH0 | |
| LVSKNSAMKEAFKAQ | 3336 | Q8WXH0 | |
| AYLNLAQKCVDQMKK | 336 | Q8NDZ6 | |
| KVTGNVSKKTNYLVM | 436 | P35251 | |
| EQMKEYAQALKNSFK | 1451 | Q5K651 | |
| NMSKVVDSLYNKAKK | 406 | O00231 | |
| FYKESKQQALSNMKT | 116 | Q53QZ3 | |
| NEVVAIKKMSYSGKQ | 51 | Q7L7X3 | |
| LLNAYQSKIKMQAEA | 811 | Q7L7X3 | |
| NYFKETVKALAGMQK | 301 | Q8TF30 | |
| KMNGYISNANYSVKK | 241 | P40692 | |
| RFYSQQMKGKQLAIK | 406 | Q07889 | |
| KNQYKLKKGMVFSIN | 366 | Q9Y5B9 | |
| MKVLNSIAYKATVNA | 831 | Q8N122 | |
| NLKVVNYFSSRNIKM | 696 | Q14246 | |
| FLKAQQKYTNIVKEM | 476 | Q8IYE0 | |
| METKMALNYQSKSQK | 271 | P98196 | |
| TKMALNYQGKSQKRS | 271 | Q8NB49 | |
| QNRKNTSFMLKVTQY | 76 | Q96PP4 | |
| LAKQMIGYNLATKQT | 116 | Q96I99 | |
| MSVAGLKKQFYKASQ | 1 | Q99961 | |
| AYNINNIGIKAMVKK | 601 | Q8N0X7 | |
| NYDSKTKNNDIALMK | 336 | O15393 | |
| KTVNKKSQLMCQQMY | 256 | Q14587 | |
| MFTKKLGNTNKNKEY | 21 | Q8NB66 | |
| KLIQQYKEAMSNKAC | 386 | Q13064 | |
| QKNSMDKKNGKSYEN | 156 | Q7Z417 | |
| ESFKLAVSQMKQQKY | 1371 | Q8NI35 | |
| VYQSMTKKAAITLQK | 236 | Q9NXL6 | |
| SMTRFYANLQKAVKQ | 196 | Q9NSY2 | |
| KSKKRLNMTSFNIAQ | 6 | Q8IV35 | |
| AFQQKDASKYQELMK | 111 | Q8WXW3 | |
| QYAAFKMQRKSKKGQ | 1126 | O60281 | |
| KLTKTAMRANYKNNS | 101 | Q9P0W8 | |
| MQQKTKLFLQALKYS | 1 | Q4J6C6 | |
| LKQSKNMILDQAFKY | 51 | Q68DE3 | |
| YQTAKKQDKNKMSAY | 251 | Q14CB8 | |
| KKKNGNYCVLQMDQS | 356 | P31939 | |
| AYTEATKAQRKQQMA | 806 | Q15393 | |
| IKIFKYISFNKTMTQ | 451 | Q9P0L9 | |
| KMKRQSYLNSANVEA | 1071 | Q9C0G0 | |
| EYTLFMSALKVNKNN | 431 | Q6ZXV5 | |
| KTAAVANSMNYLTKK | 731 | Q9NYU2 | |
| NNCVKVYNKLKLMAT | 281 | Q9P1Q0 | |
| QASKEAQKMQSEKVY | 361 | O76041 | |
| CMKVTAQNSDKNYKA | 446 | P20929 | |
| QIKYKQSAEMEKANF | 6046 | P20929 |